Skip to content
mapperlab
← Dashboard
Stock

NEOG

Neogen Corporation
Health CareHealth Care SuppliesLatest close $8.564 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
4
27 funds tracked
Ever held
6
Current + past
New this quarter
1
Exited this quarter
2

Marquee-fund ownership over time

Aug 13, 2021May 15, 2025Feb 12, 2026May 15, 2026
Now
4

This quarter's activity

New positions opened

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates re-entered$42$8.56-80%
Citadel Advisors$16$8.56-46%
AQR Capital Management$16$8.56-46%
Millennium Management re-entered$16$8.56-46%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
D.E. Shaw→ $8.19+49%
Renaissance Technologies→ $8.43-22%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at NEOGEN CORP. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
3
Filings · last 90d
4
Total on file
607
Recent SEC buffer
Most recent
Jun 4, 2026

30d / 90d windows measured from Jun 4, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 607 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · Neogen Corporation

Annual figures sourced directly from Neogen Corporation's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$894.66M
FY2025-3% YoY
Net income
-$1.09B
FY2025-500%+ YoY
EPS (diluted)
$-5.03
FY2025-500%+ YoY
Free cash flow(?)
$58.24M
FY2025+65% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for NEOGEN CORP — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Bridgewater AssociatesQ2 2026open$8.19$8.86+8%
Millennium ManagementQ1 2026open$11$8.56-22%
Renaissance TechnologiesQ1 2026Q2 2026$11$8.43-22%
Bridgewater AssociatesQ4 2025Q1 2026$6.37$11+72%
D.E. ShawQ3 2025Q2 2026$5.50$8.19+49%
Millennium ManagementQ2 2025Q4 2025$6.56$6.39-3%
Citadel AdvisorsQ3 2024open$16$8.56-46%
AQR Capital ManagementQ3 2024open$16$8.56-46%
Millennium ManagementQ3 2024Q1 2025$16$9.83-38%
Bridgewater AssociatesQ3 2021Q2 2025$42$6.38-85%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.